Skip to main content
Clinical Trials/IRCT2014061118061N1
IRCT2014061118061N1
Completed
未知

A therapeutic and side effects comparison between Rosastim and Brand type (Neupogen) in gastric cancer

Behin Tamin Rosamed Co.0 sites60 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Gasteric cancer.
Sponsor
Behin Tamin Rosamed Co.
Enrollment
60
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Behin Tamin Rosamed Co.

Eligibility Criteria

Inclusion Criteria

  • inclusion criteria: 1\.Patients with gastric cancers, age 18\-65, both sex 2\.Biopsy and pathology results 3\.Filling the consent form through patients or guardian 4\.Possible cooperation of patients till the study completed.
  • exclusion criteria: 1\.Ill\-informed patient consent for participation in the study 2\.Initial CBC disruption, so that lead to the wrong result in lab tests 3\.Hypersensitivity to one type of Granolocyte Colony Stimulating Factor 4\.History of treated malignancy or co\-current malignancy 5\.patient may require radiation during treatment 6\.recurrent gastric cancer or refractory one that have previously been treated 7\.Inappropriate performance status for start or continue treatment 8\.Mental illness or depression such that the compliance reduce.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials